bpc 157 mechanisms of action review BPC-157 in sports medicine: regenerative potential, clinical evidence and anti-doping challenges Regeneration or Risk? A Narrative
Description
Reconstitution volumes and diluent choice for investigational peptides are specified in the trial protocol and IMPD they are not appropriate for individual self-use
Some patients may require imaging studies (ultrasound, CT scanning) or referral to hepatology, haematology, or oncology services
STEP UP dose-arm dysesthesia 0.5 / 6 / 22.9%
Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions
